New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...

A new AI-powered tool can detect cognitive impairment early, helping to reduce the risk of Alzheimer's and dementia.

Baer, who is a nurse at Huntsville Hospital, said her sensory blankets are designed to provide comfort to patients.

Laromestrocel (Lomecel-B™) has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for Alzheimer's disease ...

A person's 'bioenergetic age' -- or how youthfully their cells generate energy -- might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research shows. The study ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter ...

Autoimmunity and Alzheimer’s. People with autoimmune disorders in the UCSF (left) and Stanford medical systems (right) were ...

Both FDA-approved medications are designed to remove amyloid beta plaques from the brains of people with early-stage Alzheimer's disease, potentially slowing the rate of cognitive decline.

Imagine a robot that not only reminds you to take your medication, but helps you navigate your home and offers companionship.

They include therapies designed to target neuronal tau tangles, which pulverize and kill brain cells from the inside, and others that go after the inflammation tied to Alzheimer's. Increasingly ...

Scientists have discovered that a modified form of a natural compound found in rosemary and sage may hold potential for ...